SIGGF (Sigma Healthcare) Beneish M-Score: -1.35 (As of Jun. 24, 2026)


SIGGF Sigma Healthcare Ltd SIGGF
59 GF Score
Price $2.35
GF Value $0.31
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Beneish M-Score?

Sigma Healthcare SIGGF 59 Beneish M-Score is -1.35 as of Jun. 24, 2026. GuruFocus rates SIGGF with a GF Score™ of 59/100 and a GF Value™ of $0.31. The stock has 8 warning signs investors should review. Among 113 Medical Distribution companies, Sigma Healthcare ranks worse than 88.5% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.35 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Sigma Healthcare's Beneish M-Score or its related term are showing as below:

SIGGF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.92   Med: -2.69   Max: -1.35
Current: -1.35

During the past 13 years, the highest Beneish M-Score of Sigma Healthcare was -1.35. The lowest was -3.92. And the median was -2.69.


Sigma Healthcare Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Beneish M-Score Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.41 -2.45 -3.34 -2.78 -1.35

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.78 0.00 -1.35 0.00

SIGGF vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Sigma Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Beneish M-Score falls into.


SIGGF
59GF Score
Sigma Healthcare Ltd SIGGF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sigma Healthcare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6742+0.528 * 1.3362+0.404 * 0.8552+0.892 * 1.3496+0.115 * 1.042
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8315+4.679 * 0.154775-0.327 * 0.6112
=-1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jan25) TTM:Last Year (Jan24) TTM:
Total Receivables was $210 Mil.
Revenue was $3,023 Mil.
Gross Profit was $182 Mil.
Total Current Assets was $606 Mil.
Total Assets was $919 Mil.
Property, Plant and Equipment(Net PPE) was $181 Mil.
Depreciation, Depletion and Amortization(DDA) was $16 Mil.
Selling, General, & Admin. Expense(SGA) was $195 Mil.
Total Current Liabilities was $246 Mil.
Long-Term Debt & Capital Lease Obligation was $84 Mil.
Net Income was $-9 Mil.
Gross Profit was $46 Mil.
Cash Flow from Operations was $-197 Mil.
Total Receivables was $231 Mil.
Revenue was $2,240 Mil.
Gross Profit was $180 Mil.
Total Current Assets was $477 Mil.
Total Assets was $817 Mil.
Property, Plant and Equipment(Net PPE) was $202 Mil.
Depreciation, Depletion and Amortization(DDA) was $19 Mil.
Selling, General, & Admin. Expense(SGA) was $174 Mil.
Total Current Liabilities was $332 Mil.
Long-Term Debt & Capital Lease Obligation was $149 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(210.391 / 3023.255) / (231.207 / 2240.057)
=0.069591 / 0.103215
=0.6742

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(180.392 / 2240.057) / (182.206 / 3023.255)
=0.08053 / 0.060268
=1.3362

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (605.508 + 181.133) / 919.429) / (1 - (476.946 + 202.396) / 817.371)
=0.144424 / 0.168869
=0.8552

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3023.255 / 2240.057
=1.3496

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(18.794 / (18.794 + 202.396)) / (16.082 / (16.082 + 181.133))
=0.084968 / 0.081546
=1.042

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(194.922 / 3023.255) / (173.701 / 2240.057)
=0.064474 / 0.077543
=0.8315

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((84.169 + 246.37) / 919.429) / ((148.846 + 331.959) / 817.371)
=0.359505 / 0.588233
=0.6112

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8.624 - 45.701 - -196.63) / 919.429
=0.154775

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sigma Healthcare has a M-score of -1.46 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.35 mean?
Sigma Healthcare (SIGGF) has a Beneish M-Score of -1.35 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Sigma Healthcare and its competitors. According to the industry distribution chart, Sigma Healthcare ranks #100 out of 113 companies in the Medical Distribution industry, placing it in the top 88.5%.
Is Sigma Healthcare's Beneish M-Score too high?
Sigma Healthcare's current Beneish M-Score is -1.35. Based on the distribution chart, Sigma Healthcare ranks #100 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sigma Healthcare has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #100 out of 113 companies for Beneish M-Score. This places Sigma Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Sigma Healthcare and its competitors. Sigma Healthcare's current Beneish M-Score is -1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Sigma Healthcare (SIGGF) has a current Beneish M-Score of -1.35. The stock's GF Value™ is $0.31, compared to a current price of $2.35 — trading 657.4% above its estimated fair value. The current Beneish M-Score is -1.35. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Sigma Healthcare (SIGGF), the current Beneish M-Score is -1.35 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (SIGGF) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of $2.35 is trading 657.4% above its estimated GF Value™ of $0.31.

Key valuation signals for SIGGF:

  • Beneish M-Score: -1.35
  • GF Value™: $0.31 vs. price of $2.35 (657.4% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the SIGGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sigma Healthcare Business Description

Other Exchanges SIG:Australia
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for SIGGF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price
$0.31
GF Value